Stereotactic Body Radiotherapy (SBRT) With Biologically Equivalent Dose > 150 Gy is Associated With Improved Local Control in Patients With Squamous but not Non-Squamous Cell Carcinoma of the Lung: A Multi-Institutional Analysis

MLA

Jacob S Parzen, et al. “Stereotactic Body Radiotherapy (SBRT) With Biologically Equivalent Dose > 150 Gy Is Associated With Improved Local Control in Patients With Squamous but Not Non-Squamous Cell Carcinoma of the Lung: A Multi-Institutional Analysis.” International Journal of Radiation Oncology*Biology*Physics, vol. 111, Nov. 2021, p. S127. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2021.07.289.

APA

Jacob S Parzen, Andrew Hope, José Belderbos, Inga S. Grills, Maria Werner-Wasik, Thomas J. Quinn, Meredith Giuliani, Rainer J. Klement, Hong Ye, J.J. Sonke, M. Guckenberger, K.C. Lee, & Muayad F. Almahariq. (2021). Stereotactic Body Radiotherapy (SBRT) With Biologically Equivalent Dose > 150 Gy is Associated With Improved Local Control in Patients With Squamous but not Non-Squamous Cell Carcinoma of the Lung: A Multi-Institutional Analysis. International Journal of Radiation Oncology*Biology*Physics, 111, S127. https://doi.org/10.1016/j.ijrobp.2021.07.289

Chicago

Jacob S Parzen, Andrew Hope, José Belderbos, Inga S. Grills, Maria Werner-Wasik, Thomas J. Quinn, Meredith Giuliani, et al. 2021. “Stereotactic Body Radiotherapy (SBRT) With Biologically Equivalent Dose > 150 Gy Is Associated With Improved Local Control in Patients With Squamous but Not Non-Squamous Cell Carcinoma of the Lung: A Multi-Institutional Analysis.” International Journal of Radiation Oncology*Biology*Physics 111 (November): S127. doi:10.1016/j.ijrobp.2021.07.289.